MedPath

BEYOND Weight Loss Maintenance Study

Not Applicable
Completed
Conditions
Obesity
Interventions
Dietary Supplement: Continuous energy restriction
Dietary Supplement: Intermittent energy restriction
Registration Number
NCT02683798
Lead Sponsor
NHS Greater Glasgow and Clyde
Brief Summary

A study to determine the effectiveness of two weight loss maintenance interventions in Counterweight Plus, a structured weight management programme.

Detailed Description

Introduction: Long-term maintenance of non-surgical weight loss remains the most significant problem in obesity treatment. This study will compare the effectiveness of two different weight loss maintenance strategies used as part of the Counterweight Plus weight management programme. This study will also evaluate the behavioural impact of the Counterweight Plus interventions and include process evaluations and cost analysis.

Methods: 80 patients and 10 practitioners will be recruited into the study. Main inclusion criteria for patients are:

Completed Counterweight Plus, which includes 12-20 weeks total diet replacement (TDR), 8 weeks food reintroduction (FR) and achieved \>10kg weight loss. All participants will be followed up for 18 months in total.

Results: The primary outcome of this study is the difference in weight change between the two groups at 6 months. Frequency of use of behavioural strategy will be quantified for both practitioners and patients during voice recorded consultations. The relationship between weight change and the use of behavioural strategy will be assessed.

Hypothesis: This study will establish if the novel intermittent use of formula diet strategy is more effective at preventing weight regain in comparison to usual care. It will also provide evidence of the frequency of use of behavioural strategies within routine Counterweight Plus delivery, as well as establishing the cost of the intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
63
Inclusion Criteria
  • Completed Counterweight Plus Total Diet Replacement and Food Reintroduction stages and achieved >10kg weight loss
Exclusion Criteria
  • People currently participating in another clinical research trial (not including BEYOND Weight Loss study)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Continuous energy restrictionContinuous energy restriction1 x formula food (202-209kcal) meal replacement per day
Intermittent energy restrictionIntermittent energy restriction4 x formula food (202-209kcal) total diet replacement per day, on 2 days per week
Primary Outcome Measures
NameTimeMethod
Weight changeBaseline, 26 weeks

Difference between the two groups in change in body weight (kg)

Secondary Outcome Measures
NameTimeMethod
AcceptabilityBaseline, 26 weeks, 52 weeks, 78 weeks

Number of clinic appointments attended as a proportion of the total number offered

Weight changeBaseline, 52 weeks, 78 weeks

Change in body weight (kg)

Behavioural strategies78 weeks

Number of times behaviour change strategies used, assessed by qualitative analysis/coding of consultations

Eating behavioursBaseline, 26 weeks, 52 weeks, 78 weeks

Change measured using Three Factor Eating Questionnaire- R18 (TFEQ-R18)

Quality of lifeBaseline, 26 weeks, 52 weeks, 78 weeks

Change measured using EuroQoL-5D (EQ-5D)

Cost of interventions78 weeks

Difference between groups

Trial Locations

Locations (3)

NHS Greater Glasgow and Clyde

🇬🇧

Glasgow, United Kingdom

NHS Lothian

🇬🇧

Edinburgh, United Kingdom

NHS Highland

🇬🇧

Inverness, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath